Apollomics Statistics
NASDAQ: APLMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.54-1.16 (-6.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Apollomics by the numbers
Apollomics has a market capitalization of $45.3 million based on 2.91M shares outstanding. With trailing EPS of $-0.25, Apollomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.0% below its 50-day average and 17.6% below its 200-day average.
Average daily trading volume is 11.07K shares, or about $171,988 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
APLM valuation vs. peer median
| Metric | APLM | Peer median | Difference |
|---|---|---|---|
| Market cap | $45.28M | $45.73M | -1% |
| Avg. volume | 11.07K | 827.29K | -99% |
Peer median across 8 companies: RNXT, QUCY, HOWL, GANX, MIST, TNXP, ANVS, VRCA.
Valuation
- Market cap
- $45.28M
- EPS (TTM)
- $-0.25
- Shares outstanding
- 2.91M
Price and trading
- Previous close
- 16.69
- Open
- 16.00
- Day range
- 15.54 – 16.51
- 52-week range
- 12.58 – 28.29
- 52-week change
- +7.43%
- Beta
- —
- Volume
- 4.07K
- Average volume
- 11.07K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 45.28M
- Forward Pe
- -23.90
- Eps
- -0.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.29
- Week52 Low
- 12.58
- Avg Volume
- 11,071.00
- Shares Outstanding
- 2.91M
- Ma50
- 20.99
- Ma200
- 18.85
- Pct From52w High
- -45.09%
- Pct From52w Low
- 23.49%